FEATURE ARTICLES
Research Manager Mathini Ilancheran explores the effects of U.S. drug tariffs on global supply chains, multinational pharma firms, and critical partners across drug development.
- Extreme Weather Is Testing Pharma's Resilience — Is It Ready?
- Risk-Based Analytical Method Selection In Cleaning Validation Using ASTM International Standards
- Eco-Friendly HBL: Cheaper, Cleaner, And Ready For Pharma
- Import Product Specifications And Drug Registration Testing For China
- Trust But Verify: Validating AI In Pharma's GxP World
- Roll Call In The Oral GLP-1 Race
- Derisking AI Means First Asking: Who Does It Serve?
PHARMA ONLINE WHITE PAPERS
-
Compliance With Annex 1- Sterile Fill Finish
Eurofins ensures Annex 1 compliance through robotic isolators, PUPSIT, contamination control strategies, and rigorous training for aseptic sterile fill-finish of early-phase clinical products.
-
Preclinical Immuno-Oncology Models For CAR T-Cell Therapy Development5/21/2025
The following preclinical IND-enabling oncology studies conducted by scientists at Aragen over the past 10 years highlight the role of robust preclinical models in advancing the fight against cancer.
-
Membrane Filter Pore Size Impact On Colony Size, Microbial Recovery1/31/2024
Explore results from a study evaluating the effects of different pore sizes on colony size and microbial recovery using membrane filters.
-
The Complete Guide To Immunohistochemistry9/24/2024
Immunohistochemistry (IHC) is a tool for visualizing the distribution and localization of antigens within tissue sections. Learn about IHC sample preparation, detection and amplification systems, and more.
-
Mitigating Early Development Risks9/11/2024
Discover how the efficient screening of biologic candidates accelerates the discovery process, reduces costs, and improves the likelihood of commercializing safe and effective drugs.
-
Economic Advantage Of Robotic Gloveless Pharmaceutical Isolators4/28/2025
Are robotic gloveless isolators the key to smarter, safer, scalable solutions? Discover how they can revolutionize aseptic filling by reducing contamination, minimizing waste, and enhancing manufacturing flexibility.
PHARMA ONLINE APP NOTES & CASE STUDIES
NEWSLETTER ARCHIVE
- 10.16.25 -- 10 Ways To Strengthen U.S. API: Part I
- 10.16.25 -- STREAM Edition: Improving Peptide Yields Upstream
- 10.15.25 -- The Future Of Oral Solid Dose: Technologies Shaping Tomorrow's Treatments
- 10.15.25 -- The Case for Real-Time Facility Monitoring
- 10.15.25 -- Accelerating Pharma 4.0: Intelligent Validation, Modular Automation, And AI-Driven Quality

INDUSTRY NEWS
-
Pfizer Strengthens Obesity Foothold With Metsera Acquisition
After discouraging efforts to bring two oral obesity drugs to market—danuglipron and lotiglipron—this acquisition launches Pfizer back into the obesity therapeutic game.
-
FDA Cracks Down On GLP-1 Imports
GLP-1 bulk drug substances must be detained without physical examination (DWPE) unless they are on a list (Green List) of approved foreign GLP-1 manufacturers.
-
Oregon Court Upholds Drug Price Transparency Law
The law was first enacted in 2018, followed by a lawsuit by Pharmaceutical Research and Manufacturers of America (PhRMA) in 2019, claiming an infringement of free speech for pharmaceutical companies and violation of public property. PhRMA asked the court to bar Oregon from enforcing the law.
-
Spray Drying Market Poised To Nearly Double By 2033
The growth of the spray drying market is attributed to demand for enhanced stability, bioavailability and solubility of poorly soluble drugs.
-
AbbVie Enters Psychedelic Market With Bretisilocin Acquisition
Bretisilocin is a next-generation psychedelic compound (5-HT2A receptor agonist and 5-HT releaser) designed to exert a shorter duration of psychoactive experience, while retaining an extended therapeutic benefit
PHARMACEUTICAL ONLINE CONTENT COLLECTIONS

Explore how sterility assurance, including sterilization validation and environmental monitoring, is essential for controlling microbial contamination in mammalian cell production to ensure patient safety. Check out the latest e-book from Pharmaceutical Online.
More Content CollectionsSUPPLIER NEWS
-
Ensera Launches As New Brand Identity For SteriPack10/14/2025
New trading name reflects expanded expertise across design, manufacturing, assembly and packing for global pharma and medical device companies.
-
Jubilant HollisterStier LLC Launches New High-Speed Isolator Based Line, At Its Spokane Manufacturing Facility In The US10/14/2025
Jubilant Pharmova Limited announced today that Jubilant HollisterStier LLC (JHS)—a wholly owned subsidiary and a leading North American pharmaceutical contract manufacturer, specialising in sterile injectables and serving top global innovator pharma companies—successfully launched its New Sterile Fill & Finish line, third at its Spokane Manufacturing Facility in Washington, US. The launch was marked by the successful production of the inaugural batch, initiating revenue generation from the new Line. This milestone denotes a significant advancement in Jubilant HollisterStier's multi-phase expansion strategy and brings an additional 50% capacity at its Spokane manufacturing facility.
-
Ypsomed Investing $195M Into Holly Springs, NC Drug Manufacturing Facility10/10/2025
Ypsomed announced plans Oct. 9 to invest $195.4M in Holly Springs for its first North American manufacturing facility. The company will purchase and customize an existing 110,000-square-foot building in the YIELD Holly Springs. This purpose-built manufacturing campus is part of the broader Holly Springs Business Park, located just off N.C. 55. Ypsomed has committed to creating 62 high-quality jobs.
-
Lupin To Build New Drug Manufacturing Facility In Coral Springs, Florida10/10/2025
Global pharmaceutical leader, Lupin, today announced its plans for a new state-of-the-art pharmaceutical manufacturing plant in Coral Springs, a significant step in safeguarding the health and safety of Florida families and the nation.
-
Groninger Invests In The Future: Building A state-Of-The-Art Assembly Hall At Its Crailsheim Headquarters10/8/2025
groninger is expanding: A new assembly hall and adjoining office complex are being built, covering more than 75,000 square feet. With an investment volume of over 30 million euros, it marks the largest single investment in the company’s history.